OncologiaMedica.net
Neurologia
OncoGinecologia.net
Ematologia.net

MetabolismNews.net

Metabolism Xagena

Statins are the treatment of choice for dyslipidemia, primarily lowering elevated LDL-C levels and reducing the occurrence of major cardiovascular events. In June 2011, the FDA ( Food and Drug Admin ...


Adding the drug Ezetimibe to treatment with Simvastatin lowers the risk of future cardiovascular problems, including myocardial infarction and stroke, in high-risk patients with acute coronary syndrom ...


The FDA ( Food and Drug Administration ) has approved the New Drug Application ( NDA ) for Saxenda ( Liraglutide 3 mg ), the first once-daily human glucagon-like peptide-1 ( GLP-1 ) analogue for the t ...


It is unclear whether high-density lipoprotein ( HDL ) cholesterol concentration plays a causal role in atherosclerosis. A more important factor may be HDL cholesterol efflux capacity, the ability of ...


The European Medicines Agency ( EMA ) has recommended granting a marketing authorisation for Mysimba ( Naltrexone / Bupropion ) for weight management of overweight or obese adults. The medicine is rec ...


Data, published in The Lancet, from two phase 3 studies, RUTHERFORD-2 and TESLA with Evolocumab, a novel investigational low-density lipoprotein cholesterol ( LDL-C )-lowering medication, resulted in ...


Results from four Phase 3 ODYSSEY trials of Alirocumab in people with hypercholesterolemia. Alirocumab is an investigational monoclonal antibody targeting PCSK9 ( proprotein convertase subtilisin / k ...


By inhibiting apolipoprotein B ( ApoB ) synthesis, Mipomersen ( Kynamro ) can significantly reduce ApoB-containing lipoproteins in hypercholesterolemic patients. The purpose of a study was to ascer ...


Homozygous familial hypercholesterolaemia ( HoFH ) is a rare life-threatening condition characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol ( LDL-C ) and accel ...


A meta-analysis of individual participant data of eight prospective cohort studies from Europe and the US has investigated the association between serum 25-hydroxyvitamin D concentrations [ 25(OH)D ] ...


Thirty-six percent of adults in the United States are obese, and many cannot lose sufficient weight to improve health with lifestyle interventions alone. Researches have conducted a systematic revi ...


National and international guidelines recommend fasting lipid panel measurement for risk stratification of patients for prevention of cardiovascular events. Yet, the prognostic value of fasting versus ...


Vitamin-D insufficiency is associated with many disorders, leading to calls for widespread supplementation. Some investigators suggest that more clinical trials to test the effect of Vitamin-D on diso ...


In short-term randomized trials ( duration, 1 to 2 years ), bariatric surgery has been associated with improvement in type 2 diabetes mellitus. Researchers have assessed outcomes 3 years after the ...


Efficacy and safety of Alirocumab were compared with Ezetimibe ( Ezetrol, Zetia ) in hypercholesterolemic patients at moderate cardiovascular risk not receiving statins or other lipid-lowering therapy ...